Sarepta Therapeutics' use of the priority review voucher for KEBILIDI could boost its competitive edge in pediatric gene therapies. Exciting times ahead! #Sarepta $SRPT #GeneTherapy #Biotech 🚀
#Sarepta #SRPT #GeneTherapy #Biotech